Claim your 30% discount on Global Market Reports with code ONLINE30. Limited time only.

Claim your 30% discount on Global Market Reports with code ONLINE30. Limited time only.

What Are the Latest Market Insights for the Methenamine Hippurate Tablets Industry?

The market for methenamine hippurate tablets has seen a significant expansion in the recent past. The market value is projected to escalate from $9.52 billion in 2024 to $10.11 billion in 2025, representing a compound annual growth rate (CAGR) of 6.2%. The notable advancement during the past years is due to factors such as conventional UTI treatment, apprehension about antibiotic resistance, clinical affirmation, doctors’ prescribing practices, and the inclination of patients towards non-antibiotic therapies.

In the coming years, the methenamine hippurate tablets market is projected to experience significant growth, reaching a valuation of $13.47 billion by 2029 with a 7.4% compound annual growth rate (CAGR). This expansion during the forecasted period is linked with the increasing cases of UTI, heightened worries about antibiotic resistance, advances in UTI treatment, preventive healthcare emphasis, and ongoing clinical trials and research. The forecast period will see an increased incidence of UTIs, growing antibiotic resistance, a preference for non-antibiotic therapies, a focus on preventive healthcare, and research and development.

Download The Free Sample Report Here:

https://www.thebusinessresearchcompany.com/sample.aspx?id=9412&type=smp

What Forces Are Driving The Growth Of The Methenamine Hippurate Tablets Industry?

The growth of the methenamine hippurate tablets market is predicted to be fueled by the rise in the ageing population. This term refers to individuals who are 60 years old or older. These older patients are more susceptible to urinary tract infections due to various reasons, including reduced urine flow, an enlarged prostate, or kidney stones, necessitating the use of methenamine hippurate tablets for treatment. For example, the World Health Organization, a United Nations agency based in Switzerland that deals with global public health, projects that by 2030, one in six people worldwide will be 60 or older. In 2022, there were 1.4 billion people aged 60 and over. The global population of 60-year-olds is projected to double by 2050 (2.1 billion), while the number of 80-year-olds is expected to triple, reaching 426 million. Thus, the rise in the geriatric population acts as a catalyst for the growth of the methenamine hippurate tablets market.

What Is The Overview Of Market Segmentation In The Methenamine Hippurate Tablets Industry?

The methenamine hippurate tablets market covered in this report is segmented –

1) By Type: 20 Tablets Or Bottle, 6 Tablets Or Bottle

2) By Distribution Channel: Hospital Pharmacy, Online Pharmacy, Retail Pharmacy

3) By Application: Uncomplicated UTIs, Healthcare-associated UTIs

4) By End User: Hospitals, Homecare, Specialty Clinics, Others End Users

Subsegments:

1) By 20 Tablets per Bottle: Standard Packaging, Bulk Packaging Options

2) By 6 Tablets per Bottle: Standard Packaging, Sample Or Trial Packaging

What Future Market Trends Are Projected For The Methenamine Hippurate Tablets Industry?

The primary trend picking up pace in the methenamine hippurate tablets market is the advent of product innovations. To fortify their market stand, leading firms in this sector are creating inventive products. For example, EQL Pharma, a European pharmaceutical enterprise that designs and commercializes reasonably-priced generic and niche medicines for pharmacies and hospitals, disclosed in May 2023 the out-licensing of Memprex (methenamine hippurate) to Laboratoires Majorelle for the French market distribution. This move enhances its accessibility and provides a non-antibiotic alternative for UTI prevention. Laboratoires Majorelle, a frontrunner in women’s health in France, has taken up the marketing and distribution of Memprex, presenting a non-antibiotic remedy for UTI prevention.

Who Are The Primary Players Operating Across The Global Methenamine Hippurate Tablets Market?

Major companies operating in the methenamine hippurate tablets market include Alvogen Lux Holdings S.ÀR.L., Micro Labs Inc., Aurobindo Pharma, Amneal Pharmaceuticals Inc., Viatris Inc., McKesson Corporation, Sun Pharmaceutical Industries Ltd., Cipla Ltd., Dr. Reddy’s Laboratories Ltd., Cadila Healthcare Ltd., Torrent Pharmaceuticals Ltd., Glenmark Pharmaceuticals Ltd., Zydus Pharmaceuticals Ltd., Lupin Ltd., Alkem Laboratories Ltd., Ipca Laboratories Ltd., Granules India Ltd., Teva Pharmaceutical Industries Ltd., Apotex Pharmachem Inc., Sandoz International GmbH

Get The Full Report Here:

https://www.thebusinessresearchcompany.com/report/methenamine-hippurate-tablets-global-market-report

Which Region Offers The Most Growth Potential For The Methenamine Hippurate Tablets Market Through 2029?

North America was the largest region in the methenamine hippurate tablets market in 2024. The regions covered in the methenamine hippurate tablets market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa

Request For A Customized Report:

https://www.thebusinessresearchcompany.com/customise?id=9412&type=smp

About The Business Research Company:

With over 15000+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Armed with 1,500,000 datasets, the optimistic contribution of in-depth secondary research, and unique insights from industry leaders, you can get the information you need to stay ahead in the game.

Get in touch with us:

The Business Research Company: https://www.thebusinessresearchcompany.com/

Americas +1 310-496-7795

Asia +44 7882 955267 & +91 8897263534

Europe +44 7882 955267

Email us at info@tbrc.info

Follow us on:

LinkedIn: https://in.linkedin.com/company/the-business-research-company

YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ

Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model